Northern Trust Corp 10x Genomics, Inc. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 648,810 shares of TXG stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
648,810
Previous 591,862 9.62%
Holding current value
$10.5 Million
Previous $22.2 Million 43.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$19.45 - $37.37 $1.11 Million - $2.13 Million
56,948 Added 9.62%
648,810 $12.6 Million
Q1 2024

May 14, 2024
BUY
$36.08 - $54.3 $4.41 Million - $6.64 Million
122,227 Added 26.03%
591,862 $22.2 Million
Q4 2023

Feb 13, 2024
SELL
$34.32 - $57.55 $84,084 - $140,997
-2,450 Reduced 0.52%
469,635 $26.3 Million
Q3 2023

Nov 13, 2023
BUY
$40.86 - $62.98 $473,935 - $730,505
11,599 Added 2.52%
472,085 $19.5 Million
Q2 2023

Aug 11, 2023
BUY
$50.96 - $58.72 $195,431 - $225,191
3,835 Added 0.84%
460,486 $25.7 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $2.08 Million - $3.29 Million
58,937 Added 14.82%
456,651 $25.5 Million
Q4 2022

Feb 13, 2023
BUY
$24.4 - $41.3 $116,607 - $197,372
4,779 Added 1.22%
397,714 $14.5 Million
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $180,591 - $333,473
6,341 Added 1.64%
392,935 $11.2 Million
Q2 2022

Aug 12, 2022
SELL
$36.95 - $82.41 $3.26 Million - $7.26 Million
-88,125 Reduced 18.56%
386,594 $17.5 Million
Q1 2022

May 13, 2022
BUY
$55.7 - $145.79 $294,374 - $770,500
5,285 Added 1.13%
474,719 $36.1 Million
Q4 2021

Feb 08, 2022
SELL
$135.05 - $182.59 $6.8 Million - $9.2 Million
-50,359 Reduced 9.69%
469,434 $69.9 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $6.14 Million - $8.1 Million
42,144 Added 8.82%
519,793 $75.7 Million
Q2 2021

Aug 13, 2021
BUY
$134.22 - $202.37 $9.23 Million - $13.9 Million
68,786 Added 16.82%
477,649 $93.5 Million
Q1 2021

May 12, 2021
BUY
$140.25 - $196.86 $1.84 Million - $2.59 Million
13,132 Added 3.32%
408,863 $74 Million
Q4 2020

Feb 11, 2021
BUY
$126.47 - $163.7 $13.6 Million - $17.6 Million
107,242 Added 37.17%
395,731 $56 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $9.21 Million - $13.2 Million
105,361 Added 57.53%
288,489 $36 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $9.26 Million - $14.2 Million
158,666 Added 648.62%
183,128 $16.4 Million
Q1 2020

May 14, 2020
BUY
$51.57 - $106.62 $91,639 - $189,463
1,777 Added 7.83%
24,462 $1.52 Million
Q4 2019

Feb 14, 2020
BUY
$46.07 - $79.54 $666,678 - $1.15 Million
14,471 Added 176.17%
22,685 $1.73 Million
Q3 2019

Nov 13, 2019
BUY
$49.99 - $62.0 $410,617 - $509,268
8,214 New
8,214 $414,000

Others Institutions Holding TXG

# of Institutions
287
Shares Held
94.9M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email